General Information of Drug Therapeutic Target (DTT) (ID: TTO3HT7)

DTT Name Transforming growth factor beta (TGFB)
Synonyms TGF-beta
Gene Name TGFB
DTT Type
Clinical trial target
[1]
UniProt ID
NOUNIPROTAC
TTD ID
T06011

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
11 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bintrafusp alfa DMB9LRJ Non-small-cell lung cancer 2C25 Phase 2 [2]
Fresolimumab DMFZ084 Brain cancer 2A00 Phase 2 [3]
LY2382770 DMH3YKJ Diabetic kidney disease GB61.Z Phase 2 [4]
M7824 DMJCULI Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
NIS793 DM8LBYT Pancreatic ductal carcinoma 2C10.0 Phase 2 [1]
TEW-7197 DM2LBC3 Myeloproliferative neoplasm 2A20 Phase 2 [1]
ACE-011 DMJ36YH Anemia 3A00-3A9Z Phase 1 [5]
AVID200 DMZ39T6 Solid tumour/cancer 2A00-2F9Z Phase 1 [6]
BCA101 DMM0VBU Solid tumour/cancer 2A00-2F9Z Phase 1 [7]
GS-1423 DMS25DL Solid tumour/cancer 2A00-2F9Z Phase 1 [8]
RG6440 DMVQXFH Aggressive cancer 2A00-2F9Z Phase 1 [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Clinical Trial Drug(s)
1 Preclinical Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
SHP-627 DMHAONP Cardiac arrest MC82 Preclinical [10]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF- and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial. J Thorac Oncol. 2020 Jul;15(7):1210-1222.
3 Focal Irradiation and Systemic TGF Blockade in Metastatic Breast Cancer. Clin Cancer Res. 2018 Jun 1;24(11):2493-2504.
4 A phase I dose-escalation study to a predefined dose of a transforming growth factor-1 monoclonal antibody (TM1) in patients with metastatic cancer. Int J Oncol. 2014 Dec;45(6):2221-31.
5 Clinical pipeline report, company report or official report of Acceleron Pharma (2011).
6 TGF signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome. J Clin Invest. 2019 Jun 18;129(9):3821-3826.
7 ClinicalTrials.gov (NCT04429542) Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors. U.S. National Institutes of Health.
8 Clinical pipeline report, company report or official report of Agenus.
9 Clinical pipeline report, company report or official report of Roche
10 Drugs and Targets in Fibrosis. Front Pharmacol. 2017 Nov 23;8:855.